title: Challenges of the green supply chain management in the pharmaceutical industry
metadata.name: dc.contributor.author
metadata.value: Fetter, Barbara
metadata.lang: -
metadata.name: dc.contributor.author
metadata.value: Zilahy, Gyula
metadata.lang: -
metadata.name: dc.date.accessioned
metadata.value: 2022-08-10T14:27:47Z
metadata.lang: -
metadata.name: dc.date.available
metadata.value: 2022-08-10T14:27:47Z
metadata.lang: -
metadata.name: dc.date.issued
metadata.value: 2022-06
metadata.lang: -
metadata.name: dc.identifier.citation
metadata.value: Fetter, B., and Zilahy, G. (2022) ‘Challenges of the green supply chain management in the pharmaceutical industry’, St Petersburg University Journal of Economic Studies, 38 (2), pp. 235– 258.
metadata.lang: en_GB
metadata.name: dc.identifier.other
metadata.value: https://doi.org/10.21638/spbu05.2022.204
metadata.lang: -
metadata.name: dc.identifier.uri
metadata.value: http://hdl.handle.net/11701/37290
metadata.lang: -
metadata.name: dc.description.abstract
metadata.value: Green supply chain management has gained significant interest in recent years; however, we
  still have limited understanding of specific characteristics of different industries. The aim of
  this paper is to characterize the pharmaceutical supply chains from an environmental perspective.
  Our methodology provides a novel contribution to the literature describing green
  supply chain management, since no detailed analysis of the environmental aspects of the pharmaceutical
  industry has been carried out this way. Our results can inform pharmaceutical
  businesses and policymakers about the limiting factors of green supply chain management
  in the pharmaceutical sector and provide insights to overcome hindrances and to design new
  tools. By looking at the supply chains of the pharmaceutical sector, we demonstrate that the
  potentials of green supply chain management may be limited by several factors. First, the relationship
  between pharmaceutical substance suppliers and medicinal product manufacturers
  is characterized by long-term partnerships and strong interdependence. Second, interviews
  suggest that consumers neither have environmental expectations towards medicinal products,
  nor act in an environmentally conscious manner regarding the disposal of medicinal
  products. Third, our findings on actual environmental measures implemented by companies
  suggests that the specific characteristics of pharmaceutical supply chains, such as strict quality
  and health requirements, impose severe limitations on the greening of supply chains. This
  study builds on the analysis of the international literature, through which it presents the issues
  of green supply chains in the pharmaceutical industry. Our research can be useful to national
  and international readers as well.
metadata.lang: en_GB
metadata.name: dc.language.iso
metadata.value: en
metadata.lang: en_GB
metadata.name: dc.publisher
metadata.value: St Petersburg State University
metadata.lang: en_GB
metadata.name: dc.relation.ispartofseries
metadata.value: St Petersburg University Journal of Economic Studies;Volume 38; Issue 2
metadata.lang: -
metadata.name: dc.subject
metadata.value: corporate sustainability
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: green supply chain management
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: pharmaceutical industry
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: green chemistry
metadata.lang: en_GB
metadata.name: dc.title
metadata.value: Challenges of the green supply chain management in the pharmaceutical industry
metadata.lang: en_GB
metadata.name: dc.type
metadata.value: Article
metadata.lang: en_GB
resources.filename: 04.pdf
resources.url: https://dspace.spbu.ru/bitstream/11701/37290/1/04.pdf
resources.format: Adobe PDF
resources.size: 783,15 kB